PDCT eliminates antistimulator and preserves anti–third-party CTLp and normal hematopoietic progenitor cells.

(A) Effect of TH9402 and medium treatment of MLR-activated cells (AB*) on the frequency of CTLp cells directed against stimulator B* and third-party C* cells. Results are expressed as mean ± SEM of 3 experiments. (B) Mobilized PB progenitors from 5 healthy donors were treated with TH9402 or medium. Results are expressed as mean ± SEM of CFU-GM and CFU-mix colonies.